Imugene (ASX:IMU) secures core US patent

02Oct

Imugene (ASX:IMU) secures core US patent

 

Immuno-oncology company, Imugene (ASX:IMU) has been granted a patent from the US United States Patent and Trademark Office which it says protects its cancer growth factor immunotherapy platform.

The patent protects the method of composition and method of use of Imugene’s Ohio State University licensed vaccines out to 2035.

The company says this is a core US patent in the world’s largest pharmaceutical market.

Shares in Imugene (ASX:IMU) are trading 5.9 per cent higher at 5 cents.
 
Copyright 2020 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

07Jan

Tigers Realm Coal (ASX:TIG) completes $3.7M retail entitlement offer

07 Jan 2021 - Tiger Realms Coal (ASX:TIG) has successfully completed the retail component of its renounceable entitlement offer.

Read More
19Nov

Immutep Limited (ASX:IMM) completes $29.6m placement to expand clinical development

19 Nov 2020 - Immutep Limited (ASX:IMM) is advancing clinical development for its lead product candidate eftilagimod alpha through the expansion of its ongoing TACTI-002 study and a new Phase II trial.

Read More
07Dec

Stocks of the Hour: Red Mountain Mining, 4DS Memory, Golden Deeps

07 Dec 2022 - A snapshot of the stocks on the move featuring Red Mountain Mining (ASX:RMX), 4DS Memory (ASX:4DS) and Golden Deeps (ASX:GED).

Read More
27Jan

Ampol (ASX:ALD) successfully completes $300 million off-market share buy-back

25 Jan 2021 - Ampol (ASX:ALD) has successfully completed a $300 million off-market share buy-back.

Read More
28Jan

Synlait Milk (ASX:SM1) increases forecast milk price

28 Jan 2020 - Synlait Milk (ASX:SM1) has updated its forecast base milk price for the 2019 / 2020 season to $7.25 kgMS from $7.00 kgMS.

Read More
18May

Stocks of the Hour: Charter Hall, Woodside Petroleum & Rex

18 May 2021 - Our snapshot of notable stocks for the hour featuring Charter Hall, Woodside Petroleum & Rex.

Read More
16Apr

Inghams Group (ASX:ING) Board appointed

16 Apr 2020 - Inghams Group (ASX:ING) has appointed Michael Ihlein to its Board.

Read More
08Apr

Stocks of the Hour: Alice Queen, Aurora Labs, Qoria

08 Apr 2024 - A snapshot of the stocks on the move, featuring Alice Queen (ASX:AQX), Aurora Labs (ASX:A3D) and Qoria (ASX:QOR).

Read More
01Feb

Stocks of the Hour: Singular Health Group, Mako Gold, Red Metal

01 Feb 2024 - A snapshot of the stocks on the move, featuring Singular Health Group (ASX:SHG), Mako Gold (ASX:MKG) and Red Metal (ASX:RDM).

Read More
06May

Mesoblast (ASX:MSB) dose first COVID-19 patients in Phase 2/3 trial

06 May 2020 - Mesoblast (ASX:MSB) today announced that the first patients have been dosed in the 300-patient randomized placebo-controlled Phase 2/3 trial in the United States of Mesoblast’s remestemcel-L in COVID-19 infected patients.

Read More